Depression Management Walkthrough

Depression • Clinical Path

Not sure what to do when a patient isn’t getting better on an antidepressant?

A practical way to think through non-response in outpatient depression care — before you reflexively keep titrating, switch too early, or add a second medication without a clear reason.

Takes about 2–3 minutes
Step 1 of 6
Is this actually depression?
Step 1

Is this actually depression?

Before adjusting medications, step back. Are you looking at a depressive disorder — or something that looks similar on the surface?

Quick orientation: not every low mood state is major depression, and treatment gets muddy fast when that distinction is missed.
  • Some patients have clear syndromic depression with anhedonia, guilt, hopelessness, and functional decline.
  • Some are primarily dealing with grief, burnout, medical illness, substance effects, or circumstantial sadness.
  • And some have been labeled “depression” for years without much diagnostic precision at all.
The trap: treating every low mood state as if it were the same problem — then assuming the medication failed when the diagnosis was never fully clear.
You do not need perfect diagnostic certainty. But you do need enough clarity to know whether you are treating a depressive disorder, a chronic low-mood pattern, or something else entirely.
Step 2

What kind of depression picture is this?

Not all depression presentations behave the same way over time — and that matters when you interpret response.

General direction: when the picture is episodic, it is often easier to track whether treatment is restoring the person toward baseline functioning.
General direction: when the picture is chronic, treatment may still help a great deal — but the response is often slower, less dramatic, and easier to underestimate.
The trap: judging every patient by the same response expectations, even when one is in a discrete episode and another has felt this way for years.
Step 3

Has there been a real medication trial?

Before calling something “non-response,” make sure the medication actually had a fair chance to work.

Clinical anchor: “this med didn’t work” is often not the same thing as “this med had a true trial.”
  • Was the dose pushed beyond the starting range?
  • Was there enough time at a useful dose to judge response?
  • Was adherence good enough that you are actually evaluating the medication and not an inconsistent exposure?
The trap: switching too quickly, or accepting a vague history of “I’ve tried everything” without clarifying dose, duration, and consistency.
Step 4

What kind of response are you seeing?

This is the decision point that matters most. “Not better” can mean very different things.

General direction: a true lack of response pushes you to rethink the medication strategy itself rather than simply stay the course.
General direction: partial response is different. It tells you the antidepressant may be doing something — just not enough yet.
General direction: sometimes early improvement reflects hope, expectancy, or an initial placebo boost rather than the full pharmacologic effect. That does not automatically mean the medication has failed.
The trap: treating all non-response the same, when “none,” “some,” and “not yet clear” should lead you in different directions.
Step 5

What direction fits best now?

Once you know what kind of response you’re seeing, the next move becomes much clearer.

General direction: sometimes the right answer is not a new medication but a better trial of the one already in front of you.
General direction: when there is no real response, changing classes often makes more sense than layering on complexity too early.
General direction: augmentation becomes more compelling when the antidepressant is helping but still leaving substantial symptoms behind.
The trap: augmenting a medication that never really helped, or switching away from one that was beginning to work but had not been interpreted correctly.
Step 6

Has the problem changed?

At a certain point, this stops being a simple “which antidepressant next?” question.

Clinical shift: sometimes the issue is no longer medication selection — it is that the depression is more complex than it first appeared.
  • Two real medication trials with no meaningful response
  • Persistent functional impairment despite treatment
  • Ongoing suicidality or major diagnostic uncertainty
  • A growing sense that this is not behaving like straightforward outpatient depression
The trap: cycling through medications without changing the frame, instead of recognizing when the problem now calls for a broader strategy or higher level intervention.
This does not mean you have failed. It means the question may now include behavioral activation, psychotherapy, more advanced augmentation, or specialty-level treatments like TMS, ECT, or ketamine-based care.
Next Step

Continue with the full framework

You’ve just worked through the core outpatient question: is this diagnostic uncertainty, an inadequate trial, partial response, or a sign that the problem now needs a broader frame?

The full course turns that into a more complete, reusable system for diagnosing depression accurately, choosing first-line treatment more deliberately, and knowing when to optimize, switch, augment, or escalate.

  • Distinguish depression from common mimics like grief, burnout, and medical contributors
  • Choose and titrate first-line medications more intentionally
  • Interpret non-response and partial response more clearly
  • Understand when and how to switch or augment medications
  • Use the course workspace, clinical tools, and patient handouts in real practice
$149
discounted from $179
Walkthrough-completion discount code: DEPRESSIONGUIDE30
You can use that code even if you view the full course page first and purchase afterward.
Sample the full course experience Get the course now for $149
This is for clinicians who want a calmer, more organized way to think through depression treatment — especially when the first medication does not produce a clean, obvious win.